Related references
Note: Only part of the references are listed.Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis Phase 3 Randomized Trial
Steven Yeh et al.
OPHTHALMOLOGY (2020)
Intravitreal injections of bevacizumab plus methotrexate versus bevacizumab alone for the treatment of diabetic macular edema: A randomized, sham-controlled trial
Farhad Fazel et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2020)
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
Hamid Ahmadieh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS A Randomized, Phase 2 Study (DOGWOOD)
Steven Yeh et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
Horace Massa et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration Results with Ranibizumab from the TREND Study
Rufino Silva et al.
OPHTHALMOLOGY (2018)
Mechanisms of macular edema: Beyond the surface
Alejandra Daruich et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema A DRCR Network Phase 2 Randomized Clinical Trial
Raj K. Maturi et al.
JAMA OPHTHALMOLOGY (2018)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY RETINA (2018)
Factors influencing intravitreal bevacizumab and triamcinolone treatment in patients with diabetic macular edema
Tai K. Kim et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)
Samantha Fraser-Bell et al.
OPHTHALMOLOGY (2016)
Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2016)
Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion Six-Month Results of BRIGHTER
Ramin Tadayoni et al.
OPHTHALMOLOGY (2016)
Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model
Mei Chen et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Arup Das et al.
OPHTHALMOLOGY (2015)
COMPARISON OF INTRAVITREAL TRIAMCINOLONE ACETONIDE VERSUS INTRAVITREAL BEVACIZUMAB AS THE PRIMARY TREATMENT OF CLINICALLY SIGNIFICANT MACULAR EDEMA
Qingyun Liu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2014)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Share Paper
